October 30, 2018
DNA-damaging agents, or “DDAs,” make up the most widely used group of cancer drugs. Yet their therapeutic success has been curtailed by drug resistance—either present in cancer cells from the disease onset or arising during treatment. Now, biologists at the University of California San Diego have discovered a new way […]
